ClinConnect ClinConnect Logo
Search / Trial NCT05217108

A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study

Launched by M.D. ANDERSON CANCER CENTER · Jan 31, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The TEXT2MOVE study is a research trial designed to see if an 8-week texting program can help people reduce the amount of time they spend sitting each day. This is important because sitting for long periods can negatively affect our health. The study is open to adults aged 18 and older who own a smartphone, have access to WiFi or mobile data, and can read and understand English. Participants should be sitting for more than 6 hours a day and be willing to receive text messages and answer short questionnaires on their phone.

If you join the study, you can expect to receive regular text messages that encourage you to be more active and provide tips for living a healthier lifestyle. You'll also be asked to keep track of your sitting time and activities. It’s a great opportunity to engage with your community and learn more about maintaining a healthy lifestyle while helping researchers understand how texting can motivate people to move more. Remember, you cannot participate if you have medical conditions that prevent you from walking or if you are not currently sitting for long periods.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • 1. \>18 years old
  • 2. owns a smart phone
  • 3. has access to WiFi or willing to use mobile data
  • 4. has an email address or willing to create an email address
  • 5. able to read and understand English;
  • 6. able to give informed consent;
  • 7. willing to receive text messages and complete brief questionnaires on their smart phone
  • 8. self-reports sedentary behavior (\> 6 hours/day of sitting time).
  • Exclusion criteria:
  • 1. unwilling to have sedentary behavior and activity tracked
  • 2. unable to walk without ambulatory assistance device (i.e. cane or walker) or due to underlying medical condition
  • 3. MD Anderson employees that report to the Principal Investigators of this study
  • 4. family or household member already enrolled into study
  • 5. not sedentary based on \< 6 hours/day of sitting time, and (6) currently participating in a weight management or exercise study or program

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Karen Basen-Engquist, MD

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials